IHSN Survey Catalog
  • Home
  • Microdata Catalog
  • Citations
  • Login
    Login
    Home / Central Data Catalog / ZAF_2022_CVACS-S2_V01_M
central

COVID-19 Vaccine Survey 2022
Survey 2

South Africa, 2022
Get Microdata
Reference ID
ZAF_2022_CVACS-S2_v01_M
Producer(s)
Southern Africa Labour and Development Research Unit
Metadata
DDI/XML JSON
Study website
Created on
Mar 07, 2023
Last modified
Mar 07, 2023
Page views
4742
Downloads
201
  • Study Description
  • Data Dictionary
  • Downloads
  • Get Microdata
  • Identification
  • Version
  • Scope
  • Coverage
  • Producers and sponsors
  • Sampling
  • Survey instrument
  • Data collection
  • Data Access
  • Contacts
  • Metadata production
  • Identification

    Survey ID number

    ZAF_2022_CVACS-S2_v01_M

    Title

    COVID-19 Vaccine Survey 2022

    Subtitle

    Survey 2

    Country
    Name Country code
    South Africa ZAF
    Study type

    Public Opinion Survey

    Abstract

    The COVID-19 Vaccine Survey (CVACS) is a South African national panel study of individuals initially unvaccinated against COVID-19. CVACS is implemented by the Southern Africa Labour and Development Research Unit (SALDRU) based at the University of Cape Town. The same respondents are interviewed twice, a few months apart, in 2021 and then 2022, to gather information about their attitudes, beliefs and intentions regarding COVID-19 vaccination. The purpose of CVACS is to collect high quality, timely, and relevant information on facilitators and barriers to COVID-19 vaccine uptake - including vaccine hesitancy and access constraints - to contribute to the development of data-driven campaigns and programmes to increase COVID-19 vaccination uptake in South Africa. In comparison to Survey 1, Survey 2 collected data on unvaccinated and vaccinated respondents. Final data files are:
    Unvaccinated (as was in S1)
    Vaccinated (New to S2)
    derived (As in S1)
    Link_File (New in S2 - this links the panel)

    Kind of Data

    Sample survey data [ssd]

    Unit of Analysis

    Households and individuals

    Version

    Version Description

    Version 1.0.0: Edited anonymised data for public distribution.

    Version Date

    2022

    Scope

    Notes

    CVACS measures multiple outcomes, such as vaccination knowledge, attitudes, and beliefs (including specific concerns); vaccination intentions (plans to get vaccinated), vaccine access constraints, and information seeking.

    Coverage

    Geographic Coverage

    CVACS was not designed to be, and should not be used as a prevalence study. The data cannot be considered to be nationally representative of all unvaccinated individuals in South Africa.

    Geographic Unit

    The data is at the country level. Because of the size of the sample, it is not advised to generate any aggregate results at sub-national levels including at the level of province or lower levels of geography.

    Producers and sponsors

    Primary investigators
    Name Affiliation
    Southern Africa Labour and Development Research Unit University of Cape Town
    Funding Agency/Sponsor
    Name Role
    Bill and Melinda Gates Foundation Funding agency

    Sampling

    Sampling Procedure

    CVACS Survey 1 was obtained from a stratified sample drawn from the GeoTerraImage (GTI) 2021 sampling frame (https://geoterraimage.com/), using individuals aged eighteen and older. The sample was primarily stratified across the following categories: province, population group, geographic area type (metro, non-metro urban, non-metro rural) and the neighbourhood lifestyle index (NLI), in groups of NLI 1-2, NLI 3-4, and NLI 5-10. Age categories defined according to the COVID-19 vaccination age groups (18-34, 35-49, 50-59, 60+), and gender were used as further explicit stratification variables. A credit bureau database was linked to this database at the enumeration area level, including individuals who had applied for credit, regardless of the outcome, and individuals who have had a credit check.

    The CVACS Sample in Survey 2 included individuals from Survey 1 who were re-interviewed, who fell into two categories: vaccinated between Survey 1 and 2, or those remaining unvaccinated. In order to realise an unvaccinated sample of similar size to Survey 1, a top-up sample of unvaccinated individuals was interviewed. These individuals were drawn from the same sampling frame as Survey 1. Younger and female respondents were less likely to be re-interviewed in Survey 2. The full Survey 2 unvaccinated sample is more skewed to the younger age categories, due to higher vaccination rates among the elderly precluding many from inclusion into the study.

    Weighting

    The CVACS Survey 2 data includes cross-sectional survey design weights for the full Survey 2 sample of vaccinated and unvaccinated individuals. Panel weights are included for the sample of individuals from Survey 1 who were re-interviewed in Survey 2, whether vaccinated or unvaccinated. Weighted CVACS data, whether design or panel-weighted, is not nationally representative of all unvaccinated individuals in South Africa. Design-weighted CVACS Survey 2 data corrects for non-response and uneven inclusion probabilities within the sampling frame. Panel-weighted CVACS data corrects for a degree of attrition bias. With very high rates of non-response and attrition, the weighting adjustments are unlikely to account for all selection bias in non-response or self-reported vaccination status, or for attrition bias across Survey 1 and 2.

    Survey instrument

    Questionnaires

    Data was collected for Survey 2 with two questionnaires, one for vaccinated and one for unvaccinated respondents. CVACS used computer-assisted telephone interviews (CATI). The CVACS questionnaires were translated into all South African languages and interviews were conducted in the preferred language of the respondent. Most of the survey questions collected individual-level data, with some household level data also collected through the individual questionnaire.

    Data collection

    Dates of Data Collection
    Start End Cycle
    2022-02-23 2022-03-25 Survey 2
    Mode of data collection
    • Computer Assisted Telephone Interview
    Data Collectors
    Name
    Ask Afrika
    Supervision

    CVACS was approved by the Ethics in Research Committee (EiRC) of the Faculty of Commerce, University of Cape Town on 9 November 2021.

    Data Access

    Access authority
    Name Affiliation URL Email
    DataFirst University of Cape Town support.data1st.org support@data1st.org
    Access conditions

    Public access data for use under a Creative Commons CC-BY (Attribution-only) License

    Citation requirements

    COVID-19 Vaccine Survey (CVACS) 2022, Survey 2 [dataset]. Version 1. Cape Town: Bill and Melinda Gates Foundation [funding agency]. Cape Town: Southern Africa Labour and Development Research Unit [producer], 2022. Cape Town: DataFirst [distributor], 2022. DOI: https://doi.org/10.25828/Y6FM-1K12

    Contacts

    Contacts
    Name Affiliation Email URL
    DataFirst Support University of Cape Town support@data1st.org www.support.data1st.org

    Metadata production

    DDI Document ID

    DDI_ZAF_2022_CVACS-S2_v01_M

    Producers
    Name Affiliation Role
    DataFirst University of Cape Town Metadata producer
    Development Economics Data Group The World Bank Metadata adapted for Microdata Library
    Date of Metadata Production

    2023-03-02

    Metadata version

    DDI Document version

    Version 01 (March 2023): This metadata was downloaded from the DataFirst website (https://www.datafirst.uct.ac.za/dataportal/index.php/catalog/central) and it is identical to DataFirst DDI version (zaf-saldru-cvacs-2022-s2-v1). The following two metadata fields were edited - Document ID and Survey ID.

    Back to Catalog
    IHSN Survey Catalog

    © IHSN Survey Catalog, All Rights Reserved.